Pages that link to "Q36276395"
Jump to navigation
Jump to search
The following pages link to CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells (Q36276395):
Displaying 50 items.
- Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species (Q22253929) (← links)
- Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1 (Q24290677) (← links)
- CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo (Q24296427) (← links)
- Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake (Q24302047) (← links)
- CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs (Q24304430) (← links)
- Novel antiangiogenic pathway of thrombospondin-1 mediated by suppression of the cell cycle (Q24314834) (← links)
- The CRIPTO/FRL-1/CRYPTIC (CFC) domain of human Cripto. Functional and structural insights through disulfide structure analysis (Q24315719) (← links)
- Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis (Q24316639) (← links)
- Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner (Q24321591) (← links)
- Thrombospondin-1-induced apoptosis of brain microvascular endothelial cells can be mediated by TNF-R1 (Q24336644) (← links)
- CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood (Q24521485) (← links)
- Thrombospondin 2 inhibits microvascular endothelial cell proliferation by a caspase-independent mechanism (Q24531386) (← links)
- Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism (Q24535504) (← links)
- Thrombospondins use the VLDL receptor and a nonapoptotic pathway to inhibit cell division in microvascular endothelial cells (Q24654057) (← links)
- CD36: implications in cardiovascular disease (Q24678338) (← links)
- Functional evolution of ADAMTS genes: evidence from analyses of phylogeny and gene organization (Q24805033) (← links)
- Megakaryocytes, malignancy and bone marrow vascular niches (Q26862087) (← links)
- Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its management (Q26864499) (← links)
- The BAI subfamily of adhesion GPCRs: synaptic regulation and beyond (Q26864858) (← links)
- Crystal structure of the TSP-1 type 1 repeats (Q27639866) (← links)
- Expression, purification and structural characterization of functionally replete thrombospondin-1 type 1 repeats in a bacterial expression system (Q27671576) (← links)
- The metalloproteinase ADAMTS1: a comprehensive review of its role in tumorigenic and metastatic pathways (Q27687896) (← links)
- Extracellular Matrix, a Hard Player in Angiogenesis (Q28072886) (← links)
- Pro-adhesive and chemotactic activities of thrombospondin-1 for breast carcinoma cells are mediated by alpha3beta1 integrin and regulated by insulin-like growth factor-1 and CD98 (Q28140972) (← links)
- Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity (Q28141127) (← links)
- C-mannosylation and O-fucosylation of the thrombospondin type 1 module (Q28143193) (← links)
- Expression of brain-specific angiogenesis inhibitor 2 (BAI2) in normal and ischemic brain: involvement of BAI2 in the ischemia-induced brain angiogenesis (Q28198140) (← links)
- Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor (Q28212153) (← links)
- Neurovascular effects of CD47 signaling: promotion of cell death, inflammation, and suppression of angiogenesis in brain endothelial cells in vitro (Q28240979) (← links)
- Extracellular fragment of brain-specific angiogenesis inhibitor 1 suppresses endothelial cell proliferation by blocking alphavbeta5 integrin (Q28246485) (← links)
- CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1 (Q28251463) (← links)
- Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism (Q28256059) (← links)
- Lysosomal integral membrane protein II binds thrombospondin-1. Structure-function homology with the cell adhesion molecule CD36 defines a conserved recognition motif (Q28262922) (← links)
- Identification and characterization of abeta1,3-glucosyltransferase that synthesizes the Glc-beta1,3-Fuc disaccharide on thrombospondin type 1 repeats (Q28267777) (← links)
- O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation (Q28506312) (← links)
- Thrombospondin-1 is a major activator of TGF-beta1 in vivo (Q28513856) (← links)
- Identification of a novel integrin alpha 6 beta 1 binding site in the angiogenic inducer CCN1 (CYR61) (Q28513880) (← links)
- Determination of the CD148-Interacting Region in Thrombospondin-1 (Q28551843) (← links)
- CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells (Q28580132) (← links)
- Capillary sprout endothelial cells exhibit a CD36 low phenotype: regulation by shear stress and vascular endothelial growth factor-induced mechanism for attenuating anti-proliferative thrombospondin-1 signaling (Q28581719) (← links)
- The thrombospondin receptor CD47 (IAP) modulates and associates with alpha2 beta1 integrin in vascular smooth muscle cells (Q28582206) (← links)
- Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1 (Q28647132) (← links)
- CD36 inhibitors reduce postprandial hypertriglyceridemia and protect against diabetic dyslipidemia and atherosclerosis (Q28729175) (← links)
- Molecular basis of antiangiogenic thrombospondin-1 type 1 repeat domain interactions with CD36 (Q29147397) (← links)
- Mechanistic exploration of phthalimide neovascular factor 1 using network analysis tools (Q30431758) (← links)
- Dual promoter structure of mouse and human fatty acid translocase/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor alpha and gamma ligands (Q30819886) (← links)
- Thrombospondin-1 is a transcriptional repression target of PRMT6. (Q32884548) (← links)
- Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor (Q33112683) (← links)
- Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism (Q33112684) (← links)
- A proprotein convertase/MMP-14 proteolytic cascade releases a novel 40 kDa vasculostatin from tumor suppressor BAI1. (Q33112696) (← links)